Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Mesothelioma
Stage/Subtype:  localized malignant mesothelioma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-11 of 11 for your search:
Start Over
Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-0032, NCI-2012-00332, NCT01592383
Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: VS-6063-202, NCI-2013-01412, NCT01870609
Window of Opportunity Study of VS-6063 (Defactinib) in Participants With Surgical Resectable Malignant Pleural Mesothelioma.
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: VS-6063-203, NCI-2014-00284, NCT02004028
Dendritic Cell Vaccine, Recombinant Interferon Alfa, Rintatolimod, and Celecoxib After Surgery in Treating Patients with Peritoneal Surface Cancers
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 12-110, NCI-2014-01357, 02151448, NCT02151448
Chemotherapy With or Without Porfimer Sodium-Based Photodynamic Therapy During Surgery in Treating Patients With Malignant Pleural Mesothelioma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 14513, NCI-2014-01242, 819186, NCT02153229
Intrapleural Measles Virus Therapy in Patients with Malignant Pleural Mesothelioma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC1023, NCI-2011-03574, 2010UC103, NCT01503177
Photodynamic Therapy and HPPH in Treating Patients With Pleural Malignancy Who Are Undergoing Surgery
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC# 02507, NCI-2009-01539, NCT01673074
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ADU-CL-02, NCI-2012-03035, NCT01675765
Heated Cisplatin following Surgery in Treating Younger Patients with Primary or Metastatic Pleural Malignancies
Phase: Phase I
Type: Treatment
Age: 3 to 21
Trial IDs: 2012-0657, NCI-2014-01101, NCI-2014-00510, NCT01998529
Vaccine Therapy and Celecoxib in Treating Patients with Lung Cancer, Esophageal Cancer, Thymic Cancers, Thoracic Sarcomas, or Malignant Pleural Mesotheliomas Undergoing Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 11-C-0041, NCI-2013-01472, 110041, P09574, NCT01258868
Start Over